Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter October 2, 2023

Identification of sulfamethoxazole’s residues in sulfamethoxazole induced kidney stones by mass spectrometry

  • Marta Leporati ORCID logo EMAIL logo , Federica Pullara , Alessandra Canevaro , Paolo Valesella , Corrado Vitale , Domenico Cosseddu , Martino Marangella and Michele Petrarulo

Corresponding author: Marta Leporati, Laboratorio di Chimica Analitica e Calcolosi Renale, Azienda Ospedaliera Ordine Mauriziano di Torino, via Magellano 1, Torino 10128, Italy, E-mail:

  1. Research ethics: Not applicable.

  2. Informed consent: Not applicable.

  3. Author contributions: The authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Competing interests: The authors state no conflict of interest.

  5. Research funding: None declared.

  6. Data availability: The raw data can be obtained on request from the corresponding author.

References

1. Marangella, M. Medical management of urinary calculi: up to date 2016. Urologia 2016;83:110–23. https://doi.org/10.5301/uro.5000180.Search in Google Scholar PubMed

2. Tiselius, HG. Epidemiology and medical management of stone disease. BJU Int 2003;91:758–67. https://doi.org/10.1046/j.1464-410x.2003.04208.x.Search in Google Scholar PubMed

3. Daudon, M, Frochot, V, Bazin, D, Jungers, P. Drug-induced kidney stones and crystalline nephropathy: pathophysiology, prevention and treatment. Drugs 2018;78:163–201. https://doi.org/10.1007/s40265-017-0853-7.Search in Google Scholar PubMed

4. García-Galán, MJ, Díaz-Cruz, MS, Barceló, D. Identification and determination of metabolites and degradation products of sulfonamide antibiotics. Trends Anal Chem 2008;27:1008–22. https://doi.org/10.1016/j.trac.2008.10.001.Search in Google Scholar

5. Roedel, MM, Nakada, SY, Penniston, KL. Sulfamethoxazole-induced sulfamethoxazole urolithiasis: a case report. BMC Urol 2021;21:133. https://doi.org/10.1186/s12894-021-00894-5.Search in Google Scholar PubMed PubMed Central

6. DeMasi, MS, Bernstein, AP, Schulster, M, Silva, MV. 100 % N4-acetylsulfamethoxazole stone induced by Trimethoprim-Sulfamethoxazole in an HIV patient being treated for toxoplasmosis. Urol Case Rep 2021;34:101453. https://doi.org/10.1016/j.eucr.2020.101453.Search in Google Scholar PubMed PubMed Central

7. Neal Jr, MP. General case of the day. Sulfonamide crystallization in nonalkalinized urine. Radiographics 1988;8:993–6. https://doi.org/10.1148/radiographics.8.5.3227135.Search in Google Scholar PubMed

8. Albala, DM, Prien, EL, Galal, HA. Urolithiasis as a hazard of sulfonamide therapy. J Endourol 1994;8:401–3. https://doi.org/10.1089/end.1994.8.401.Search in Google Scholar PubMed

9. Rince, M, Dudognon, P, Moesch, C, Leroux-Robert, C. Urinary lithiasis induced by sulfamethoxazole in a patient with tetraplegia. Case report. Paraplegia 1992;30:750–1. https://doi.org/10.1038/sc.1992.144.Search in Google Scholar PubMed

10. Siegel, WH. Unusual complication of therapy with sulfamethoxazole-trimethoprim. J Urol 1977;117:397. https://doi.org/10.1016/s0022-5347(17)58476-1.Search in Google Scholar PubMed

Received: 2023-07-13
Accepted: 2023-09-21
Published Online: 2023-10-02
Published in Print: 2024-03-25

© 2023 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 9.5.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2023-0984/html
Scroll to top button